Company Profiles

driven by the PitchBook Platform

Altor BioScience

Description

Developer of immunotherapies designed to treat cancer and viral infections. The company's engineered cytokine technology platforms focus on the immunostimulatory properties of the cytokines IL-15 and IL-2, as well as offer links between the innate and adaptive arms of the immune system and induce the activation, proliferation and persistence of NK and T cells, which are critical in the body's defense against cancer and infection, enabling HIV infected individuals and patients with hematological tumors to regulate the function of the immune system.

2002

Founded

PRIVATE

Status

11-50

Employees

M&A

Latest Deal Type

$290M

Latest Deal Amount

$104M

Total Amount Raised

Description

Developer of immunotherapies designed to treat cancer and viral infections. The company's engineered cytokine technology platforms focus on the immunostimulatory properties of the cytokines IL-15 and IL-2, as well as offer links between the innate and adaptive arms of the immune system and induce the activation, proliferation and persistence of NK and T cells, which are critical in the body's defense against cancer and infection, enabling HIV infected individuals and patients with hematological tumors to regulate the function of the immune system.

Website:

www.altorbioscience.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Other Pharmaceuticals and Biotechnology

Primary Office

2810 North Commerce Parkway Miramar, FL 33025United States +1 (954) 443-8600
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Altor BioScience's full profile, request a free trial.

Altor BioScience Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Altor BioScience Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Altor BioScience Investors (11)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Bill & Melinda Gates FoundationNot-For-Profit Venture Capital000 0000000 0000
Hamilton LaneAsset ManagerMinority000 0000000 0000
National Cancer InstituteGovernment000 0000000 0000
National Heart, Lung and Blood InstituteOther000 0000000 0000
National Institute Of Allergy and Infectious Diseases Extramural ActivitesGovernment000 0000000 0000
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital
Hamilton Lane Asset Manager
National Cancer Institute Government
National Heart, Lung and Blood Institute Other
National Institute Of Allergy and Infectious Diseases Extramural Activites Government

Altor BioScience Executive Team (18)

NameTitleBoard
Seat
Contact
Info
Hing Wong Ph.DFounder, Board Member & Chief Executive Officer
Rick GreeneChief Financial Officer
Jeffrey Weber Ph.DConsulting Medical Director
Bee-Yau HuangDirector, Clinical Development
Fred MiddletonVice Chairman & Chief Business Officer
Hing Wong Ph.D Founder, Board Member & Chief Executive Officer
Rick Greene Chief Financial Officer
Jeffrey Weber Ph.D Consulting Medical Director
Bee-Yau Huang Director, Clinical Development
Fred Middleton Vice Chairman & Chief Business Officer

Altor BioScience Board Members (5)

NameRepresentingRoleSinceContact
Info
Adam Waldman JDSelfBoard Member000 0000
Boyden Gray JDSelfBoard Member000 0000
Fred MiddletonAltor BioScienceVice Chairman & Chief Business Officer000 0000
Hing Wong Ph.DAltor BioScienceFounder, Board Member & Chief Executive Officer000 0000
Patrick Soon-Shiong MDSelfChairman000 0000
Adam Waldman JD Board Member Self
Boyden Gray JD Board Member Self
Fred Middleton Vice Chairman & Chief Business Officer Altor BioScience
Hing Wong Ph.D Founder, Board Member & Chief Executive Officer Altor BioScience
Patrick Soon-Shiong MD Chairman Self
Request full access to PitchBook